Work

EE261 Economic Evaluation of Dupilumab Versus Standard of Care for the Treatment of Adult Patients With Moderate-to-Severe Prurigo Nodularis in the United States

Year: 2024

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2024.10.543

Authors: J Tavi, D Bahloul, A Kuznik, RB Thomas, C Knight, N Manga, S Sullivan

Institutions: Sanofi (France), Regeneron (United States), RTI Health Solutions

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4405748314

Cites:

Cited by: 1

Related to: 10